You are on page 1of 8



  
ก
% &' ()* +
,-. ./ 0
%)* ก &' (+
  02 ?
 : 
  
E-Mail: chinekhob@gmail.com

=&8 =ก 
% &' ()* + )7 4903502
-4ก5ก676ก (8 ,)0  --> 8 4ก &' ()* ก:., )* ก &' (=&4กก D'D-E D
0  &' ()* , 4ก &' ()* (Epidemiology and Principles of Disease Control)

%)* ก &' (+ D40R-R0 “7 R'” ( -S กก )
-4ก5ก676* 0)7 ก --> )7 , 4ก/ , ):<ก )
4 6)7 )* ก &' (=&4กก D'D-E D
URL: http://www.esnips.com/web/EPIDEM-1

1
1-1    !
R',R/,.[ R0 ก , < *<\ 1 (L-1) "#$ % ก
 "( )*%(*(") ก --> ก(, 

 -->    !"#$ %
 $( "2 40 "5&'6  &
!ก   (
ก7&"8 
 ก
! 
 -->   $ ก&'ก&'ก( ก&' !
 460 "5 ก .). Hippocrates "$E%$ก&ก + กก #FF
 ก ก !$)*%! ก ก กG !,ก!(&'$ ' ก(    ! &*(( +%ก(
 --> ( 
! +&ก),ก- ก "  . * ' ! . (
 $)-&' 16 Fracastoro %$ !& + *# 
$ 
# !I*ก( F 3    ก * กก) !#
6 (I(ก!

1-1    ! 1-1    !
"#$ % ก "#$ % ก 
"( )*%(*(") ก --> ()  "( )*%(*(") ก --> ()
 .).1747 James Lind F),ก-*กก # Scurvy # *(ก
ก!ก  ! Citric Acid W 6!F(ก-# &
F  $ &(กX- =*<\(4[0,()-R0
(6!ก),ก- !W  G F"!   John Snow
 .).1769 Baker F),ก-ก Colic (ก * Acute lead =(0ก-R0S_
intoxication) F"8 *W  &' '
G "^_!  
G ) /กE D
"^!_ &`"8 ก a,'GW*ก('!!ก
670) /กE D
 .).1848 John Snow %$(กX- F*(ก !$  I &' (6(
Golden Square &' London "g"8  ก#  ' Plot !W 6 &'
,-.\S` D.a. 1854
! กก( W ! 
&' #ก&'ก("i_
G&'& 3 (  *"
F&( ,'&'"8 (#

2
1-1    ! 1-1    !
"#$ % ก "#$ % ก 
"( )*%(*(") ก --> ()   ก (Epidemiology) --> ,Sc)7 ก *<\
 .).1854 John Snow ก7F*(กก ก#&'ก , 
&ก( 
 adกe 4กef&ก ,ก)( ก ก &
R0E D =&g4 Rg  6S &7 ก
 & 
F"ก&'ก( -(*
G"" 2  -( !*I*"F -e -5d0ก D  ,/=&Sh

4 ก8 (*<\-<)*:)*8 6,ก)(
" 2ก" "l_ 
G&' กก( W !&' -(F G"8

G"" ก7GWกก # กก(  (*( ( 
(F&ก(ก$ 
=&= ก &
Rd[
 ก#ก ก Vibrio Cholerae) – epi --> on, upon --> 
 .).1954 Salk Vaccine filed trail FGก! Vaccine "pก( #"! # – demos --> people, human population --> "$$ ("$ก -%)
W 7ก (ก& ก !   *G7 – logy --> the study of, knowledge --> ก),ก-, , )*%
40-< &,< (*<\ 6
*<\2(*2S<ก- ก /)(/ -/2(*<\
http://th.wikipedia.org/wiki/ &' ()*

1-1    ! 1-1    !
"#$ % ก "#$ % ก 
 ก --> )* ก &' (2-67 R )7   ก --> ()
(Discipline) =/,Sc,D .\0-. (Tools) *<\676ก adกe Shj  : fR  .
ก adกe )* ก &' ( D.ก adกe ,.\* '5d0):ก< (Methodology) 6  What is infectious disease epidemiology?
ก adกe E D=&Shj * 0ก =* =& : fR E(  SD.ก adกe *<\ A case is a risk factor w
D 'D-S &,(k8 D4j/ 0 l (40<[
Infection in one person can be transmitted to others
 กก# (Distribution), "i( (กG &'& + !ก
ก#  กก # (Determinant), "$ก -% (Human
population), ก"!&' "!# (Dynamic), `&'"8 # !FW$
# (Disease and non-disease conditions), # $ 
!#F$ 

(Infections and non-infections disease) ! ก"pก( !
(Prevention and control)

3
1-1    ! 1-1    !
"#$ % ก "#$ % ก 
 ก --> ()   ก --> ()
– Endemic (E DS &
8 5)\): Refers to a disease or infection that is particular

Number of Cases of a Disease
to a particular group of people for a very long time period. Endemic refers
to a disease that is normally occurring in a population.
– Epidemic (E D &' (): Refers to an increase in a particular disease or
infection in a group of people over what is normally occurring in the
particular population.
– Pandemic (E D &' (*4\Eก): Refers to an increase of a particular
disease or infection over what is normally occurring in the worldwide Endemic Epidemic
population. Time

1-1    ! 1-1    !
"#$ % ก "#$ % ก 
 ก -->   ก --> =0 R,*k

)0 R-*<\
 ,.\* 'R (=&ก ก &
R0E D=&g4 Rg  67-7 6 5ก/0 E( 67):<ก ' - , < ', < 0 ),D & =SD -- =&
-)/)*<\,ก<\ ก4' 'DD (Person) , (Time) =&5 *<\ (Place) 8 ,R- ,.\S &,-)g *<\*8 62(D8 /'6ก S 4'S 0=&
 ,.\* ' ,/R0E D=&g4 Rg  4p 0  : fR )* ก &' (
&7 'ก5d0E D =&g4
Rg *<\,ก)(Rd[  -<D -=/ก/ 0ก4  02 =&,Scg &,< 06(
 ,.\* ': -7 /)R0ก ,ก)(E D=&g4 Rg  Sh

4 ก8 (*<\-< 6* 0,a eqก)
=&40D-
)*:) =&):<ก 5 *(E D
 ,.\67,Sc=* 06ก  0=ก D'D-=&So0ก4ก ,ก)( 67ก &'ก =0 D - * 0)* a / *4[0 5 R4[/
E D=&g4 Rg  *4[06Sh 

'4=&6 D/ *'* D 4' -<&2 ' 0=?

4
1-1    ! 1-1    !
"#$ % ก "#$ % ก 
"#$ % ก -->  ก   "#$ % ก -->   $ก

 7 D =&
4(8 (4'D -8 D4jR0Shj  7 adกe (ก ,S<\ =S0R0ก ,ก)( ก ก &
=&=E-
R0ก ,ก)(E D
 7 6* '/,/=&Sh

4 *<\,ก<\ ก4'Shj  : fR4[ l
 67,Sc=* 06ก 6' )ก  : fR*4[0* 0( ก 0, )-
 7 6ก D)(D ./4()6
6ก 67- / ก *<\
&So0ก4=& Rg  ก D'D-So0ก4E D ก 4กe  '  =&ก rstr
D'D-E DE( *<\- / ก 4[D
&-<D - - *8 2(= g ( Rg 
=&D (ก f 2(  074(, 
 67,Sc=* 06ก adกe )
4 =&D  ,/*<\=*
)0R0
 7 /)(/ -S &,-)D -8 , k 
. 
(R0ก (8 ,)ก Shj ก ,ก)(E D =&g4 Rg  ,.\'ก):<ก =ก2R  0-<
S &)*:)g 

1-2   $ ก ก&' ! 1-2   $ ก ก&' !
 กก($)*%! ก  กก($)*%! ก 
  $ ก --> 2 "`      $ ก --> ()  . F&ก$
 )* ก &' (: Classical (Traditional) epidemiology - 5d0  &' ()* ,7)040D- (Social epidemiology) - 5d0 ก adกe
ก 67)* ก &' (*<\ d(S &7 7 .7-7,Sc4ก =&,Sc g &Rg *<\,ก<\ R0ก4')\0=(-/ 0 l =&* 040D-
ก adกe Shj R0E D/g4 Rg  67-7ud\0-0,6ก D
Sh

4 ,<\ 0 (Risk Factor) *<\
&8 2Sก So0ก4=&-<ก , < ก<ก  &' ()* Eg7 a / (Nutritional epidemiology) - 5d0
7.\ %Public Health Epidemiology+ ก adกe )* ก &' (*<\,ก<\ ก4'g &Eg7 ก
 ,7a / D))ก: Clinical epidemiology - 5d0 ก 67)* ก  ...
&' (*<\ d(5 ' )ก  : fR,Sc4ก E( -<4/5S &0D
,.\4p ก /4()6
6ก 4กe S_ *4[06=0ก ))
x4 ก
4กe =&ก  ก f E D

5
1-2   $ ก ก&' ! 1-2   $ ก ก&' !
 กก($)*%! ก  กก($)*%! ก 
  $ ก --> ()   $&'ก&' $  ก&' ! กก( z -->
"7  ก $)*%! ก
 ,7a / D))ก (Clinical medicine) "$ก&'ก&' "$กW $$ (
 6"g}&'( ก
  :))* (Pathology)
 ),ก-กก#W $$ ก ),ก-ก }( !ก(ก-#
 
7<)* (Microbiology) * * * กก"pก(
!#
 S )/)* (Parasitology)  '  (ก  6"g&'( ก
 7<5)/) (Biostatistics)
*(( +% 1 : many 1:1
 S &7 ก a / (Demography) (ก $$&"$ก
ก2{%&'W$(*G7 G  "$ก&'F7"g G  6"g&' (ก- !
 .\ l ,7 ,7a / 74 / 40<)* ...

1-3 ( 
! +&ก),ก- ก 1-3 ( 
! +&ก),ก- ก
"  . "  . 
!(กก&'W$W ก),ก- ก --> &' 2     +&ก),ก- ก --> & 3 "   
 ก ,ก)(E D (Disease occurrence) S &ก'( D (Host) /4กE D  )* ก &' (,7)0 f (Descriptive epidemiology)
(Agent) =&)\0=(- (Environment)
 )* ก &' (,7)0),D & (Analysis epidemiology)
 ก ก &
R0E D (Disease distribution) S &ก'( , (Time)
5 *<\ (Place) =&4กef&'DDR0S _ (Person) ก adกe 2SR 0 (Prospective Study)
 )\0ก8 ( (Determinant) D.Sh

4 *<\*8 6,ก)(ก ก &
R0E D-<ก ก adกe 40 (Retrospective Study)
,S<\ =S02S ก adกe f 
(, 6(, d\0 (Cross-sectional Study)
 S &7 ก - 5d0D -,Sc7-7  .
&,S < ',*< 'ก4กk/0S 4'6q   )* ก &' (,7)0*(0 (Experimental epidemiology)
,Scq ,(< ก4 ,7ก 674/ S_  . 4/ S_ / ,x &E D ,Sc/

6
1-3 ( 
! +&ก),ก- ก 1-3 ( 
! +&ก),ก- ก
"  . "  . 
 +&ก),ก- ก --> ()   +&ก),ก- ก --> ()
 )* ก &' (,7)0 f (Descriptive epidemiology)  )* ก &' (,7)0),D & (Analysis epidemiology)
adกe  E D&2 (what) ,ก)(ก4'6D (who) *<\2 (where) =&,ก)( ,ScR4[/
ก)* ก &' (,7)0 f ,.\/'D8 5 -/ ,ก)(Rd[
,-.\2  (when) 2(  02 (How) E( ,2S*<\ก adกe  D -4-4: R0Sh

4 *<\
,.\67
4(8 (4'D -8 D4j --> PDCA D.  0=So0ก4=&D'D- ,Sc ,/R0E D/g4 Rg  ud\0

&/0-<ก 8 
7-7 ก
E D & &/ 0 l --> (8 ,)ก =ก2RShj --> S &,-) --> S 4'6- 'ก &' (  .ก )
4 * 0)* ก &' (,Sc,D .\0-.
 .*8 u[8 (8 ,)ก ='0  2(,Sc...
ก adกe S=''<[
8 ,Sc/0-<R-,ก<\ ก4'E D  0D '5 5ก/0
=& (, k

1-3 ( 
! +&ก),ก- ก 1-3 ( 
! +&ก),ก- ก
"  . "  . 
 +&ก),ก- ก --> ()   +&ก),ก- ก --> ()
 )* ก &' (,7)0),D & (Analysis epidemiology) (/)  )* ก &' (,7)0*(0 (Experimental epidemiology)
ก adกe 2SR 0 (Prospective Study) ,Scก ,S < ',*< ''4/)ก f • ,Scก adกe E( 67 S=''ก *(0* 0D))ก  .ก *(06
6, .\0,/ Sh

4 ,<\ 0 =&ก-*<\2-2(4-4 7-7 ,.\ D -4-4: R0Sh

4  ,/ ,7 ก *(0R0
ก adกe 40 (Retrospective Study) ,Scก adกe ก4'2S 4Du<So0ก4E D  .- / ก /):<ก So0ก4E D/ 0 l
 ,/ .Sh

4 ,<\ 0/ก ,ScE D • 4กก 8 D4jD. 4ก Max Min Con 2(=ก ...
ก adกe f 
(, 6(, d\0 (Cross-sectional Study) ,Scก adกe
,.\:)' 5d0D -4-4: R00D S &ก'/ 0 l ก4'E D

7
1-3 ( 
! +&ก),ก- ก 1-3 ( 
! +&ก),ก- ก
"  . "  . 
 +&ก),ก- ก --> ()  กG   ก --> 3 !(ก-2  
 )* ก &' (,7)0*(0 (Experimental epidemiology) (/)  ก ,~o &40* 0)* ก &' ( (Epidemiological Surveillance)
– Maximized systematic variance - 5d0 ก *8 6D D -=S S  ,Scก)
ก -6ก /)(/ - ' -R-ก ,ก)(E D /(, ,.\* '
& 0ก-*(0-<D 0(4
&7  Sก )
4 2(5ก/0
D -,S<\ =S0 --> 0.506
– Minimized error variance - 5d0 ก  -(D -=S S g 6
ก-*(0 .D D -=S S .\l*<\2- - 5D'D-2(6-<D /\8 (  ก '* 0)* ก &' ( (Epidemiological Investigation)
):<ก ( error variance D. 1)  -6ก-/4  0*<\67adกe 6ก- ,Scก D R,*k

)06ก f<,ก)(Shj ก &' (R0E DRd[  S_
*(0=/&ก-D'D--<D -=/ก/ 0ก4 *<\( 2)  -(D -
D (,D.\R0ก 4( =& 3) -6ก 4(-<D -,*<\ 0 ( Reliability ) <[,ScE D&2 D ( 2S4-4E D
ก6D )\06( ,ก)(E DRd[2(  02
- ก*<\( =&
&7 6ก  0=
&D'D-So0ก4E D2(  02
– Control of extraneous variable - 5d0 ก D'D-/4=S ,ก)R0ก )
4  ก adกe * 0)* ก &' ( (Epidemiological Studies) ,Scก
D.  -D'D-)*:)R0/4=S *<\ ก,.
ก 
(-0- R0ก
)
4 (8 ,)ก ,.\6* ' &,< (R0Shj 64กef&/ 0 l - กRd[

8